These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7839006)

  • 1. Polymerase-chain-reaction-based semi-quantification of hepatitis D viraemia in patients treated with high doses of alpha 2b interferon.
    Dény P; Fattovich G; Le Gal F; Giustina G; Lecot C; Morsica G; Poinsot H; Alberti A; Bréchot C
    Res Virol; 1994; 145(5):287-95. PubMed ID: 7839006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of peginterferon alpha-2b in chronic hepatitis delta: relevance of quantitative RT-PCR for follow-up.
    Castelnau C; Le Gal F; Ripault MP; Gordien E; Martinot-Peignoux M; Boyer N; Pham BN; Maylin S; Bedossa P; Dény P; Marcellin P; Gault E
    Hepatology; 2006 Sep; 44(3):728-35. PubMed ID: 16941695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of hepatitis delta virus RNA in serum by consensus real-time PCR indicates different patterns of virological response to interferon therapy in chronically infected patients.
    Le Gal F; Gordien E; Affolabi D; Hanslik T; Alloui C; Dény P; Gault E
    J Clin Microbiol; 2005 May; 43(5):2363-9. PubMed ID: 15872267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of the detection of hepatitis delta virus RNA in serum by RNA hybridization and polymerase chain reaction.
    Tang JR; Cova L; Lamelin JP; Baginski I; Vitvitski L; Gaudin JL; Hantz O; Trépo C
    J Hepatol; 1994 Dec; 21(6):953-60. PubMed ID: 7535327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of hepatitis delta virus RNA by polymerase chain reaction in acute and chronic delta infection.
    Jardi R; Buti M; Cotrina M; Rodriguez F; Allende H; Esteban R; Guardia J
    Hepatology; 1995 Jan; 21(1):25-9. PubMed ID: 7528710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between Level of Hepatitis D Virus RNA at Week 24 of Pegylated Interferon Therapy and Outcome.
    Keskin O; Wedemeyer H; Tüzün A; Zachou K; Deda X; Dalekos GN; Heidrich B; Pehlivan S; Zeuzem S; Yalçın K; Gürel S; Tabak F; Idilman R; Bozkaya H; Manns M; Yurdaydin C
    Clin Gastroenterol Hepatol; 2015 Dec; 13(13):2342-49.e1-2. PubMed ID: 26044319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The French experience of treatment of chronic type D hepatitis with a 12-month course of interferon alpha-2B. Results of a randomized controlled trial.
    Gaudin JL; Faure P; Godinot H; Gerard F; Trepo C
    Liver; 1995 Feb; 15(1):45-52. PubMed ID: 7776857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis.
    Battegay M; Simpson LH; Hoofnagle JH; Sallie R; Di Bisceglie AM
    J Med Virol; 1994 Dec; 44(4):389-92. PubMed ID: 7897369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymerase chain reaction-based detection of hepatitis D virus RNA in patients infected with human immunodeficiency virus.
    Lecot C; Jeantils V; Ovaguimian L; Krivitzky A; Bréchot C; Dény P
    Prog Clin Biol Res; 1993; 382():329-35. PubMed ID: 8502699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymerase chain reaction-based detection of hepatitis D virus genome in patients infected with human immunodeficiency virus.
    Dény P; Lecot C; Jeantils V; Ovaguimian L; Krivitzky A; Bréchot C
    J Med Virol; 1993 Mar; 39(3):214-8. PubMed ID: 8468565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative analysis of hepatitis D virus RNA and hepatitis B surface antigen serum levels in chronic delta hepatitis improves treatment monitoring.
    Manesis EK; Schina M; Le Gal F; Agelopoulou O; Papaioannou C; Kalligeros C; Arseniou V; Manolakopoulos S; Hadziyannis ES; Gault E; Koskinas J; Papatheodoridis G; Archimandritis AJ
    Antivir Ther; 2007; 12(3):381-8. PubMed ID: 17591028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum hepatitis C virus (HCV)-RNA and response to alpha-interferon in anti-HCV positive chronic hepatitis.
    Magrin S; Craxì A; Fabiano C; Fiorentino G; Marino L; Almasio P; Pinzello GB; Palazzo U; Vitale M; Maggio A
    J Med Virol; 1992 Nov; 38(3):200-6. PubMed ID: 1283753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of chronic hepatitis D virus infection with low and high doses of interferon-alpha 2a: utility of polymerase chain reaction in monitoring antiviral response.
    Madejón A; Cotonat T; Bartolomé J; Castillo I; Carreño V
    Hepatology; 1994 Jun; 19(6):1331-6. PubMed ID: 8188163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic value of anti-hepatitis D virus (HDV) antibodies revisited: a study of total and IgM anti-HDV compared with detection of HDV-RNA by polymerase chain reaction.
    Huang YH; Wu JC; Sheng WY; Huo TI; Chang FY; Lee SD
    J Gastroenterol Hepatol; 1998 Jan; 13(1):57-61. PubMed ID: 9737573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with interferon-alpha2b of naive non-cirrhotic patients with chronic hepatitis C according to viraemia and genotype. Results of a randomized multicentre study. The North West Italian Hepatological Group.
    Saracco G; Ciancio A; Ghisetti V; Rocca G; Cariti G; Andreoni M; Tabone M; Roffi L; Calleri G; Ballaré M; Terreni N; Sartori M; Tappero GF; Traverso A; Poggio A; Orani A; Maggi G; Di Napoli A; Arrigoni A; Rizzetto M;
    Eur J Gastroenterol Hepatol; 2001 Feb; 13(2):149-55. PubMed ID: 11246614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of HDV-RNA by PCR in serum of patients with chronic HDV infection.
    Madejón A; Castillo I; Bartolomé J; Melero M; Campillo ML; Porres JC; Moreno A; Carreño V
    J Hepatol; 1990 Nov; 11(3):381-4. PubMed ID: 2290030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term interferon-alpha treatment of children with chronic hepatitis delta: a multicentre study.
    Di Marco V; Giacchino R; Timitilli A; Bortolotti F; Crivellaro C; Calzia R; Iannuzzi C; Prestileo T; Vajro P; Nebbia G; Stringhi C; Rosina F; Biassoni D; Callea F; Rizzetto M; Craxi A
    J Viral Hepat; 1996 May; 3(3):123-8. PubMed ID: 8871870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial.
    Bazinet M; Pântea V; Cebotarescu V; Cojuhari L; Jimbei P; Albrecht J; Schmid P; Le Gal F; Gordien E; Krawczyk A; Mijočević H; Karimzadeh H; Roggendorf M; Vaillant A
    Lancet Gastroenterol Hepatol; 2017 Dec; 2(12):877-889. PubMed ID: 28964701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Editing efficiency of hepatitis delta virus RNA is related to the course of infection in woodchucks.
    Yang A; Karayiannis P; Thomas H; Monjardino J
    J Gen Virol; 1995 Dec; 76 ( Pt 12)():3071-8. PubMed ID: 8847512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resistance of hepatitis delta virus replication to interferon-alpha treatment in transfected human cells.
    Ilan Y; Klein A; Taylor J; Tur-Kaspa R
    J Infect Dis; 1992 Nov; 166(5):1164-6. PubMed ID: 1328404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.